Khin Wee Lai
Khin Wee Lai is an expert in Medical imaging at University of Malaya (Malaysia). As of October 2026, ScienceLeadR ranks Khin Wee Lai in the top 1% of experts worldwide for Deep Learning, Machine Learning and Artificial Intelligence. Khin Wee Lai has authored 157 publications, the most recent in 2026. SLR score: 456 (community average: 125). How the SLR is computed.
LeadR Profile
Medical imaging
Subspecialties: Informatics - Neurology - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2014 - 2026
Number : 157
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Effects of Automated Massage Chair Therapy on Mental Health and Physical Health: A Comprehensive Study. PMID 42419415 — hypertension, low back pain, blood, mental fatigue, pain, stress, physiological, therapeutics, back pain, mental health, massage | Complement Ther Med | 2026 | 0 |
| Emerging Oncolytic Viruses: Beyond Adenoviruses and Herpes Simplex Virus. PMID 42327580 — cells, herpes simplex, adenoviridae, neoplasms, simplexvirus, oncolytic viruses, oncolytic virotherapy, viruses, immunity, therapeutics | J Cancer | 2026 | 2 |
| Tannic Acid as a Multifunctional Regulator in Calcium Phosphate Bone Biomaterials: Design Opportunities and Unresolved Challenges. PMID 41895043 — tannins, biocompatible materials, calcium, work | Biomater Adv | 2026 | 0 |
| High-throughput thickness analysis of 2D materials enabled by intelligent image segmentation. PMID 41427875 — microscopy, atomic force, microscopy, artificial intelligence, nanotechnology | Nanoscale | 2025 | 0 |
| Smart and injectable hydrogels for cancer treatment and other biomedical applications. PMID 41308530 — hydrogel, polyethylene glycol dimethacrylate, hydrogels, neoplasms, multiple chronic conditions, biocompatible materials, therapeutics, environment | Biomater Adv | 2025 | 0 |
LeadR Networks
Main global connection map